A TECHNIQUE FOR THE PURIFICATION OF IMMUNE COMPLEXES USING RHEUMATOID FACTORGILEAD Z; SULITZEANU D.1979; J. IMMUNOL. METHODS; NLD; DA. 1979; VOL. 30; NO 1; PP. 11-22; BIBL. 14 REF.Article

ISOLATION AND ELECTROPHORETIC ANALYSIS OF IMMUNE COMPLEXE FROM PATIENTS WITH BREAST CANCERGILEAD Z; TROY FA; SULITZEANU D et al.1981; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1981; VOL. 17; NO 11; PP. 1165-1176; BIBL. 35 REF.Article

ANTIGENS IN IMMUNE COMPLEXES FROM PATIENTS WITH BREAST CANCER: IDENTIFICATION OF AUTOANTIGENS IN IMMUNE COMPLEXES ISOLATED FROM BREAST CANCER EFFUSIONSGILEAD Z; HATZUBAI A; SULITZEANU D et al.1982; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DEU; DA. 1982; VOL. 13; NO 3; PP. 153-157; BIBL. 21 REF.Article

AN IMPROVED TECHNIQUE FOR THE ISOLATION AND ANALYSIS OF IMMUNE COMPLEXESGILEAD Z; GAZITT Y; SULITZEANU D et al.1981; J. IMMUNOL. METHODS; ISSN 0022-1759; NLD; DA. 1981; VOL. 42; NO 1; PP. 67-77; BIBL. 14 REF.Article

PURIFICATION IN MOLECULAR CHARACTERIZATION OF ADENOVIRUS TYPE 2 DNA-BINDING PROTEIN.SUGAWARA K; GILEAD Z; GREEN M et al.1977; J. VIROL.; U.S.A.; DA. 1977; VOL. 21; NO 1; PP. 338-346; BIBL. 22 REF.Article

A TECHNIQUE FOR THE IDENTIFICATION OF GLYCOPROTEIN ANTIGENS IN IMMUNE COMPLEXES AND ITS APPLICATION TO THE DETECTION OF A COMMON GLYCOPROTEIN IN SERA OF PATIENTS WITH BURKITT'S LYMPHOMA AND NASOPHARYNGEAL CARCINOMAGAZITT Y; GILEAD Z; KLEIN G et al.1981; J. IMMUNOL. METHODS; ISSN 0022-1759; NLD; DA. 1981; VOL. 43; NO 1; PP. 49-57; BIBL. 22 REF.Article

PRODUCTION OF VIRUS BY EMBRYONIC CULTURES CO-CULTIVATED WITH BREAST TUMOUR CELLS OR INFECTED WITH MILK FROM BREAST CANCER PATIENTSKEYDAR J; GILEAD Z; KARBY S et al.1973; NATURE NEW BIOL.; G.B.; DA. 1973; VOL. 241; NO 106; PP. 49-52; BIBL. 17REF.Serial Issue

IDENTIFICATION OF EARLY PROTEINS INDUCED BY HIGHLY ONCOGENIC HUMAN ADENOVIRUS 12 DURING LYTIC INFECTION AND IN HAMSTER TUMORS.CHINNADURAI G; YUN HUA JENG; GILEAD Z et al.1977; BIOCHEM. BIOPHYS. RES. COMMUNIC.; U.S.A.; DA. 1977; VOL. 74; NO 3; PP. 1199-1205; BIBL. 16 REF.Article

IMMUNOFLUORESCENCE STUDY OF THE ADENOVIRUS TYPE 2 SINGLE-STRANDED DNA BINDING PROTEIN IN INFECTED AND TRANSFORMED CELLS.SUGAWARA K; GILEAD Z; WOLD WSM et al.1977; J. VIROL.; U.S.A.; DA. 1977; VOL. 22; NO 2; PP. 527-539; BIBL. 1 P. 1/2Article

TUMOUR ANTIGEN SPECIFICITY OF A DNA-BINDING PROTEIN FROM CELLS INFECTED WITH ADENOVIRUS 2 = SPECIFICITE D'ANTIGENE DE TUMEUR D'UNE PROTEINE FIXANT L'ADN DE CELLULES INFECTEES PAR L'ADENOVIRUS 2GILEAD Z; ARENS MQ; BHADURIS S et al.1975; NATURE; G.B.; DA. 1975; VOL. 254; NO 5500; PP. 533-536; BIBL. 24REF.Article

ADENOVIRUS TYPE 2 CODED SINGLE-STRANDED DNA BINDING PROTEIN: IN VIVO PHOSPHORYLATION AND MODIFICATION.YUN HUA JENG; WOLD WSM; SUGAWARA K et al.1977; J. VIROL.; U.S.A.; DA. 1977; VOL. 22; NO 2; PP. 402-411; BIBL. 1 P.Article

Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusions of patients with malignant diseaseGILEAD, Z; ZAHAVI, R; HATZUBAI, A et al.Journal of cancer research and clinical oncology. 1983, Vol 106, Num 3, pp 195-201, issn 0171-5216Article